A class II-restricted cytotoxic T-cell clone recognizes a human minor histocompatibility antigen with a restricted tissue distribution
- PMID: 15606552
- DOI: 10.1111/j.1365-2141.2004.05283.x
A class II-restricted cytotoxic T-cell clone recognizes a human minor histocompatibility antigen with a restricted tissue distribution
Abstract
Following a human leucocyte antigen (HLA)-identical allogeneic stem cell transplantation (allo-SCT), minor histocompatibility antigens (mHags) play an important role in the induction of graft-versus-leukaemia (GvL) and graft-versus-myeloma (GvM). Many mHags show ubiquitous tissue expression and are associated with GvL and graft-versus-host disease. Here we describe a cytotoxic CD4(+) T lymphocyte line and a cytotoxic, CD4(+) T cell clone (CTC), 3AB11, which recognized a tissue-restricted mHag. This CTC was isolated from a multiple myeloma patient with clinical GvM following an HLA-matched allo-SCT. CTC 3AB11 was activated in a HLA-DP*0401 restricted fashion and the antigen was expressed by 27% of HLA-DP*0401 positive Epstein-Barr virus (EBV)-transformed B-cell lines (EBV-B). Tissue distribution analysis of antigen 3AB11 showed it to be expressed by patient-derived EBV-transformed B cell lines (EBVp), the myeloma plasma cell-line UM9 and monocytes. It was weakly expressed by peripheral blood-derived phytohaemagglutinin-induced T-cell blasts and absent on CD40L stimulated peripheral B (CD40L B) cells and stromal cells. The relatively high prevalence of the HLA class II-restricted 3AB11 antigen, together with its apparent haematopoietic-restricted expression, makes it an antigen of interest for cellular immunotherapy.
Similar articles
-
Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.Br J Haematol. 2006 Jan;132(1):56-65. doi: 10.1111/j.1365-2141.2005.05843.x. Br J Haematol. 2006. PMID: 16371020
-
Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy.Clin Cancer Res. 2007 Jul 1;13(13):4009-15. doi: 10.1158/1078-0432.CCR-07-0286. Clin Cancer Res. 2007. PMID: 17606735
-
Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL.J Immunol. 1997 Jan 15;158(2):560-5. J Immunol. 1997. PMID: 8992968
-
Targeting haematopoietic-specific minor histocompatibility antigens to distinguish graft-versus-tumour effects from graft-versus-host disease.Best Pract Res Clin Haematol. 2008 Sep;21(3):543-57. doi: 10.1016/j.beha.2008.06.001. Best Pract Res Clin Haematol. 2008. PMID: 18790454 Review.
-
[Minor antigens - major impact. The role of minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation].Dtsch Med Wochenschr. 2008 Jul;133(28-29):1511-6. doi: 10.1055/s-2008-1081100. Dtsch Med Wochenschr. 2008. PMID: 18597211 Review. German.
Cited by
-
Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells.Cancer Immunol Immunother. 2013 Feb;62(2):257-71. doi: 10.1007/s00262-012-1329-y. Epub 2012 Aug 14. Cancer Immunol Immunother. 2013. PMID: 22890822 Free PMC article.
-
Identification of minor histocompatibility antigens based on the 1000 Genomes Project.Haematologica. 2014 Dec;99(12):1854-9. doi: 10.3324/haematol.2014.109801. Epub 2014 Aug 22. Haematologica. 2014. PMID: 25150256 Free PMC article.
-
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication.Immunol Rev. 2011 May;241(1):104-18. doi: 10.1111/j.1600-065X.2011.01007.x. Immunol Rev. 2011. PMID: 21488893 Free PMC article. Review.
-
Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysis.J Exp Med. 2008 Nov 24;205(12):2863-72. doi: 10.1084/jem.20080713. Epub 2008 Nov 10. J Exp Med. 2008. PMID: 19001137 Free PMC article.
-
Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts.J Exp Med. 2010 Mar 15;207(3):637-50. doi: 10.1084/jem.20091918. Epub 2010 Feb 15. J Exp Med. 2010. PMID: 20156971 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials